Technology Transfer Facts
Technology Transfer Facts
AllerGen Knowledge and Technology Exchange and Exploitation
Intellectual property and commercial contributions resulting from AllerGen-supported research 2005-2008:
Publications
- Articles, reviews and editorials appearing in refereed publications: 120
- Articles, reviews and editorials appearing in non-refereed publications: 19
Poster presentations: 128
Network intellectual property disclosures: 5
Pending disclosures (next 6 months): 2
Patents issued: 2
Patents pending: 1
Copyrights: 1
Licences granted to industry: 1
Marketing, outreach and global branding:
BioContact Quebec, (Oct 06)
BioFinance Early Phase (Nov 06)
York BioTech Biomedical Convergence (Nov 06)
Cross Border Deals, Golden Horseshoe (Nov 06)
Networking, match-making and relationship building:
Ontario's Regional Innovation Networks
University of Guelph and CIC re: nutraceutical clinical trial testing
Discussions with NIH for potential funding opportunities.
Discussion with Merck Frosst, Sanofi-Pasteur, General Electric re: support for CHILD Study
Exploration of collaborative opportunities with StrokeNet and AFMNet
Informal marketing for affiliated company Salpep.
Updated Aug 8/08